Fractyl Health Approves 1-for-5 to 1-for-15 Reverse Stock Split

What Happened

• On September 24, 2026, Fractyl Health, Inc. (ticker: GUTS) held a Special Meeting of Stockholders and filed an 8-K reporting that shareholders approved amendments allowing the company’s board to effect a reverse stock split of common stock at a ratio between 1-for-5 and 1-for-15. The approval was certified in the filing signed by CEO Harith Rajagopalan.

Key Details

• Record date: August 21, 2026.
• Meeting participation: 111,987,852 shares represented (≈70.35% of 159,179,848 shares outstanding).
• Vote tally: 102,476,581 votes For; 9,319,450 Against; 191,821 Abstentions.
• Board discretion: The board may choose any split ratio within the approved 1-for-5 to 1-for-15 range and must take further action to implement it.

Why It Matters

• A reverse stock split reduces the number of outstanding shares and increases the per-share price proportionally; the exact effect will depend on the ratio the board selects and when it executes the split. Investors should note the measure is approved but not yet implemented — the board still needs to decide the specific ratio and timing. Potential impacts include changes to share liquidity, market perception, and compliance with listing requirements; shareholders will be informed if and when the company files further notices or a certificate amendment to effect the split.